These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35611953)

  • 41. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice.
    Yang F; Li J; Zhu J; Wang D; Chen S; Bai X
    Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydroxysafflor Yellow A Alleviates Ischemic Stroke in Rats via HIF-1[Formula: see text], BNIP3, and Notch1-Mediated Inhibition of Autophagy.
    Zhang Y; Liu Y; Cui Q; Fu Z; Yu H; Liu A; Liu J; Qin X; Ge S; Zhang G
    Am J Chin Med; 2022; 50(3):799-815. PubMed ID: 35300568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
    Hu T; Wei G; Xi M; Yan J; Wu X; Wang Y; Zhu Y; Wang C; Wen A
    Int J Mol Med; 2016 Jul; 38(1):83-94. PubMed ID: 27176815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel oral preparation of hydroxysafflor yellow A base on a chitosan complex: a strategy to enhance the oral bioavailability.
    Ma GN; Yu FL; Wang S; Li ZP; Xie XY; Mei XG
    AAPS PharmSciTech; 2015 Jun; 16(3):675-82. PubMed ID: 25511808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice.
    Zhang Y; Song L; Pan R; Gao J; Zang BX; Jin M
    Biol Pharm Bull; 2017; 40(2):135-144. PubMed ID: 28154251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous Optimization of the Ultrasonic Extraction Method and Determination of the Antioxidant Activities of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B from Safflower Using a Response Surface Methodology.
    Zhang Y; Yu L; Jin W; Li C; Wang Y; Wan H; Yang J
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32182800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats.
    He Y; Liu Q; Li Y; Yang X; Wang W; Li T; Zhang W; Cui Y; Wang C; Lin R
    J Physiol Biochem; 2015 Mar; 71(1):69-78. PubMed ID: 25626885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective Effects of Two Safflower Derived Compounds, Kaempferol and Hydroxysafflor Yellow A, on Hyperglycaemic Stress-Induced Podocyte Apoptosis via Modulating of Macrophage M1/M2 Polarization.
    Li Y; Zheng D; Shen D; Zhang X; Zhao X; Liao H
    J Immunol Res; 2020; 2020():2462039. PubMed ID: 33102606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax.
    Ji DB; Zhu MC; Zhu B; Zhu YZ; Li CL; Ye J; Zhu HB
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):191-202. PubMed ID: 18670359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action.
    Tian J; Li G; Liu Z; Fu F
    Pharmacology; 2008; 82(2):121-6. PubMed ID: 18583922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat.
    Lee M; Zhao H; Liu X; Liu D; Chen J; Li Z; Chu S; Kou X; Liao S; Deng Y; Li H; Xie W
    Oxid Med Cell Longev; 2020; 2020():7805393. PubMed ID: 32256962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydroxysafflor yellow A (HSYA) alleviates apoptosis and autophagy of neural stem cells induced by heat stress via p38 MAPK/MK2/Hsp27-78 signaling pathway.
    Li H; Liu Y; Wen M; Zhao F; Zhao Z; Liu Y; Lin X; Wang L
    Biomed Pharmacother; 2019 Jun; 114():108815. PubMed ID: 30954890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
    Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
    Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice.
    Sun CY; Pei CQ; Zang BX; Wang L; Jin M
    Phytother Res; 2010 Dec; 24(12):1788-95. PubMed ID: 20564507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Protective effect of hydroxysafflor yellow A on experimental cerebral ischemia in rats].
    Zhu HB; Wang ZH; Tian JW; Fu FH; Liu K; Li CL
    Yao Xue Xue Bao; 2005 Dec; 40(12):1144-6. PubMed ID: 16496682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway.
    Su D; Lv C
    Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A.
    Zhao B; Gu S; Du Y; Shen M; Liu X; Shen Y
    Int J Pharm; 2018 Jan; 535(1-2):164-171. PubMed ID: 29107614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydroxysafflor yellow A suppresses inflammatory responses of BV2 microglia after oxygen-glucose deprivation.
    Li J; Zhang S; Lu M; Chen Z; Chen C; Han L; Zhang M; Xu Y
    Neurosci Lett; 2013 Feb; 535():51-6. PubMed ID: 23333598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular dynamics simulation integrating the inhibition kinetics of hydroxysafflor yellow A on α-glucosidase.
    Xu Y; Lee J; Park YD; Yang JM; Zheng J; Zhang Q
    J Biomol Struct Dyn; 2018 Mar; 36(4):830-840. PubMed ID: 28264629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.
    Jiang S; Shi Z; Li C; Ma C; Bai X; Wang C
    Int J Clin Exp Pathol; 2014; 7(5):2595-608. PubMed ID: 24966974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.